Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-15 Sale | 2025-12-16 6:27 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 30,011 | $74.64 | $2,239,902 | 5,603,885 (Indirect Direct) | View |
| 2025-12-08 Sale | 2025-12-10 07:53 am | BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer | 2,000 | $74.26 | $148,520 | 130,297 (Direct) | View |
| 2025-12-04 Sale | 2025-12-08 5:54 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 80,000 | $73.86 | $5,908,476 | 4,787,223 (Indirect Direct) | View |
| 2025-11-20 Sale | 2025-11-24 6:46 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 26,156 | $65.84 | $1,722,224 | 5,622,909 (Indirect Direct) | View |
| 2025-11-17 Sale | 2025-11-19 5:08 pm | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 95,599 | $66.11 | $6,319,662 | 64,672 (Indirect Direct) | View |
| 2025-11-17 Sale | 2025-11-19 5:06 pm | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 10,000 | $66.65 | $666,465 | 57,090 (Indirect Direct) | View |
| 2025-11-17 Sale | 2025-11-18 7:28 pm | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO | 16,934 | $66.46 | $1,125,404 | 382,830 (Direct) | View |
| 2025-11-12 Sale | 2025-11-14 4:50 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 25,484 | $66.07 | $1,683,728 | 33,347 (Indirect Direct) | View |
| 2025-11-06 Sale | 2025-11-10 5:33 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 80,000 | $62.29 | $4,983,111 | 1,018,776 (Indirect Direct) | View |
| 2025-11-06 Sale | 2025-11-07 6:03 pm | BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director | 61,031 | $63.72 | $3,888,999 | 47,514 (Direct) | View |
| 2025-10-29 Sale | 2025-10-31 4:38 pm | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 198,359 | $66.58 | $13,206,528 | 763,254 (Indirect Direct) | View |
| 2025-10-27 Sale | 2025-10-29 5:10 pm | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 1,641 | $65 | $106,665 | 961,613 (Indirect Direct) | View |
| 2025-10-08 Sale | 2025-10-10 5:40 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 80,000 | $54.79 | $4,383,442 | 1,058,776 (Indirect Direct) | View |
| 2025-09-05 Sale | 2025-09-08 6:06 pm | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 74,000 | $53.16 | $3,933,544 | 1,048,068 (Indirect Direct) | View |
| 2025-09-04 Sale | 2025-09-08 6:05 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 80,000 | $52.2 | $4,175,835 | 1,098,776 (Indirect Direct) | View |
| 2025-08-21 Sale | 2025-08-22 4:58 pm | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO | 42,237 | $49.48 | $2,090,081 | 421,081 (Direct) | View |
| 2025-08-20 Sale | 2025-08-22 4:46 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 26,156 | $48.82 | $1,276,927 | 5,857,223 (Indirect Direct) | View |
| 2025-08-18 Sale | 2025-08-19 7:40 pm | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO | 17,353 | $50.23 | $871,722 | 463,318 (Direct) | View |
| 2025-08-08 Sale | 2025-08-12 7:06 pm | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 300,000 | $46.37 | $13,912,443 | 916,674 (Direct) | View |
| 2025-08-07 Sale | 2025-08-11 6:29 pm | BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer | 1,000 | $45.44 | $45,440 | 141,859 (Direct) | View |
| 2025-08-07 Sale | 2025-08-11 6:12 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 80,000 | $45.84 | $3,666,949 | 1,133,090 (Indirect Direct) | View |
| 2025-08-05 Sale | 2025-08-07 4:50 pm | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 17,167 | $49 | $841,183 | 52,923 (Direct) | View |
| 2025-07-01 Sale | 2025-07-03 4:30 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 80,000 | $42.63 | $3,410,450 | 1,173,090 (Indirect Direct) | View |
| 2025-06-27 Sale | 2025-07-01 7:48 pm | BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities Illiquid Investments Sub-Master LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 3,500,000 | $44 | $154,000,000 | 18,555,375 (Indirect) | View |
| 2025-06-26 Sale | 2025-06-30 5:51 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 4,707 | $44.05 | $207,327 | 7,863 (Indirect Direct) | View |
| 2021-12-29 Purchase(A) | 2025-06-30 5:49 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 1,752 | $14.24 | $24,948 | 5,981 (Indirect Direct) | View |
| 2021-12-28 Purchase(A) | 2025-06-30 5:46 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,338 | $12.84 | $30,028 | 4,229 (Indirect Direct) | View |
| 2025-06-24 Sale | 2025-06-26 5:08 pm | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 100,000 | $44.23 | $4,422,800 | 963,254 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-12 Exercise | 2025-12-16 6:27 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 60,975 | $0 | 5,603,885 (Direct) | View |
| 2025-12-12 Tax Withholding | 2025-12-16 6:27 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 30,964 | $75.15 | 5,603,885 (Direct) | View |
| 2025-12-12 Tax Withholding | 2025-12-16 6:25 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO | 13,826 | $75.15 | 369,004 (Direct) | View |
| 2025-12-12 Tax Withholding | 2025-12-16 6:24 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer | 2,003 | $75.15 | 128,294 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 5:06 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 10,000 | $0 | 57,090 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 5:06 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 10,000 | $16.75 | 57,090 (Direct) | View |
| 2025-11-16 Exercise | 2025-11-18 7:31 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 64,697 | $0 | 6,143,378 (Direct) | View |
| 2025-11-16 Tax Withholding | 2025-11-18 7:31 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 32,855 | $66.39 | 6,143,378 (Direct) | View |
| 2025-11-16 Tax Withholding | 2025-11-18 7:28 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO | 21,317 | $66.39 | 382,830 (Direct) | View |
| 2025-11-16 Tax Withholding | 2025-11-18 7:23 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer | 4,781 | $66.39 | 132,297 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-14 4:50 pm | N/A 2031-10-24 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 25,484 | $0 | 33,347 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-14 4:50 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 25,484 | $48.45 | 33,347 (Direct) | View |
| 2025-11-06 Exercise | 2025-11-07 6:03 pm | N/A 2030-02-11 | BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director | 61,031 | $0 | 47,514 (Direct) | View |
| 2025-11-06 Exercise | 2025-11-07 6:03 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director | 61,031 | $34.65 | 47,514 (Direct) | View |
| 2025-10-10 Other | 2025-10-16 5:54 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | BridgeBio Pharma LLC BridgeBio Pharma Inc. 10% Owner | 784,720 | $0 | 15,374,566 (Direct) | View |
| 2025-09-05 Exercise | 2025-09-08 6:06 pm | N/A 2033-02-20 | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 74,000 | $0 | 1,048,068 (Direct) | View |
| 2025-09-05 Exercise | 2025-09-08 6:06 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 74,000 | $11.92 | 1,048,068 (Direct) | View |
| 2025-08-16 Tax Withholding | 2025-08-19 7:40 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer | 4,781 | $51.32 | 137,078 (Direct) | View |
| 2025-08-16 Tax Withholding | 2025-08-19 7:40 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO | 21,317 | $51.32 | 463,318 (Direct) | View |
| 2025-08-16 Exercise | 2025-08-19 7:38 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 129,394 | $0 | 6,442,389 (Direct) | View |
| 2025-08-16 Tax Withholding | 2025-08-19 7:38 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 32,855 | $51.32 | 6,442,389 (Direct) | View |
Ownership | 2025-08-18 5:16 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | BridgeBio Pharma LLC BridgeBio Pharma Inc. 10% Owner | 0 | $0 | 13,878,554 (Direct) | View |
| 2025-08-05 Exercise | 2025-08-07 4:50 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 17,167 | $0 | 52,923 (Direct) | View |
| 2025-08-05 Exercise | 2025-08-07 4:50 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 17,167 | $16.75 | 52,923 (Direct) | View |
| 2025-06-27 Gift | 2025-06-30 5:54 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 20,000 | $0 | 1,216,674 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:13 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 15,014 | $0 | 168,696 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:12 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 15,014 | $0 | 27,014 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:10 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Cook Jennifer E. Director | 15,014 | $0 | 22,166 (Direct) | View |